Table 3.
Demographic and clinical data of COVID-19 patients sampled less than two weeks after symptoms onset
| Peak disease severity | Mild | Moderate | Severe | Significancea |
|---|---|---|---|---|
| n (%) | 7 (37) | 7 (37) | 5 (24) | |
| Age in year, median (range) | 38 (29–72) | 50 (41–65) | 49 (32–62) | 0.0775 |
| Male, n (%) | 2 (14) | 4 (56) | 4 (90) | 0.6867 |
| Female, n (%) | 5 (86) | 3 (44) | 1 (10) | |
| Comorbidities | ||||
| CCI, median (IQR) | 0 (0) | 1 (3) | 1 (2) | 0.3571 |
| BMI, median (IQR) | 23.0 (7.7) | 30.8 (8.4) | 30.6 (12.5) | 0.0273 |
| Hypertension, n (%) | 0 (0) | 1 (14) | 0 (0) | 0.4046 |
| Diabetes, n (%) | 1 (14) | 2 (28) | 1 (20) | 0.8048 |
| Current smoker, n (%) | 0 (0) | 2 (33) | 0 (0) | 0.1472 |
CCI Charlson Comorbidity Index.
aTwo-sided Kruskal–Wallis’ and Fisher’s exact tests were performed to determine statistical significance.